keyword
MENU ▼
Read by QxMD icon Read
search

"Adverse event" radiation

keyword
https://read.qxmd.com/read/30786315/digital-cholangioscopy-guided-laser-versus-mechanical-lithotripsy-for-large-bile-duct-stone-removal-after-failed-papillary-large-balloon-dilation-a-randomized-study
#1
Phonthep Angsuwatcharakon, Santi Kulpatcharapong, Wiriyaporn Ridtitid, Chaloemphon Boonmee, Panida Piyachaturawat, Pradermchai Kongkam, Wattana Pareesri, Rungsun Rerknimitr
BACKGROUND:  Endoscopic papillary large-balloon dilation (EPLBD) allows for the complete removal of large common bile duct (CBD) stones without fragmentation; however, a significant proportion of very large stones and stones floating above a tapering CBD require lithotripsy. Mechanical lithotripsy and cholangioscopy-guided laser lithotripsy are both effective for stone fragmentation. This study aimed to directly compare, for the first time, the efficacy of these two techniques in terms of stone clearance rate, procedure duration, patient radiation exposure, and safety...
February 20, 2019: Endoscopy
https://read.qxmd.com/read/30783157/radiation-pneumonitis-after-intensity-modulated-radiotherapy-for-esophageal-cancer-institutional-data-and-a-systematic-review
#2
J J Tonison, S G Fischer, M Viehrig, S Welz, S Boeke, K Zwirner, B Klumpp, L H Braun, D Zips, C Gani
Radiation pneumonitis (RP) is a serious complication that can occur after thoracic radiotherapy. The goal of this study is to investigate the incidence of RP after radiochemotherapy with intensity modulated radiotherapy (IMRT) in patients with esophageal cancer and correlate this with dose volume histogram (DVH) related parameters. For this purpose, the clinical course of 73 patients was evaluated and irradiation doses to the lungs were extracted from radiotherapy treatment plans. Furthermore, a systematic review on this topic was conducted across PubMed...
February 19, 2019: Scientific Reports
https://read.qxmd.com/read/30777633/renal-imaging-core-curriculum-2019
#3
REVIEW
Jessica G Fried, Matthew A Morgan
Renal imaging has become a fundamental part of clinical care for patients with kidney disease. Imaging strategies for the kidney have been evolving during the past hundred years and have been even more rapidly changing during the past couple of decades due to the development of modern computed tomographic techniques, magnetic resonance imaging, and more sophisticated ultrasonographic techniques, such as contrast-enhanced ultrasonography. Applying the correct radiologic study for the clinical situation maximizes the diagnostic accuracy of the imaging, and a judicious choice between techniques helps limit radiation dose and potential adverse events...
February 15, 2019: American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation
https://read.qxmd.com/read/30777253/combined-low-dose-rate-brachytherapy-and-external-beam-radiation-therapy-for-intermediate-risk-prostate-cancer
#4
Michael Chao, Daryl Lim Joon, Vincent Khoo, Sandra Spencer, Huong Ho, Mario Guerrieri, Farshad Foroudi, Damien Bolton
INTRODUCTION: This is a retrospective study conducted to report the tumor control and late toxicity outcomes of patients with intermediate-risk prostate cancer undergoing combination external beam radiation therapy and low dose rate brachytherapy (LDR-PB). METHODS AND MATERIALS: Thirty-one patients received 45 Gray (Gy) of external beam radiation therapy to the prostate and seminal vesicles, together with a brachytherapy boost via a transperineal prostate implant of I125 (108 Gy)...
March 2019: Journal of Medical Imaging and Radiation Sciences
https://read.qxmd.com/read/30776452/pravastatin-reverses-established-radiation-induced-cutaneous-and-subcutaneous-fibrosis-in-patients-with-head-and-neck-cancer-results-of-the-biology-driven-phase-ii-clinical-trial-pravacur
#5
Celine Bourgier, Anne Auperin, Sofia Rivera, Pierre Boisselier, Benoit Petit, Philippe Lang, Nathalie Lassau, Patrice Taourel, Raphael Tetreau, David Azria, Jean Bourhis, Eric Deutsch, Marie-Catherine Vozenin
PURPOSE: The "xxx" phase II trial (NCTxxx) assessed the efficacy of pravastatin as anti-fibrotic agent in patients with established cutaneous and subcutaneous radiation-induced fibrosis (RIF) after head and neck squamous cell carcinoma (HNSCC) radiotherapy and/or radio-chemotherapy. METHODS AND MATERIALS: The main inclusion criteria were: patients with HNSCC in remission, with grade ≥2 cutaneous and subcutaneous neck RIF (NCI-CTCAE v4.0); no current treatment with statins or fibrates...
February 15, 2019: International Journal of Radiation Oncology, Biology, Physics
https://read.qxmd.com/read/30773222/cisplatin-and-radiation-therapy-in-hiv-positive-women-with-locally-advanced-cervical-cancer-in-sub-saharan-africa-a-phase-ii-study-of-the-aids-malignancy-consortium
#6
Mark H Einstein, Ntokozo Ndlovu, Jeannette Lee, Elizabeth A Stier, Jeffrey Kotzen, Madhur Garg, Kathleen Whitney, Shelly Y Lensing, Mariza Tunmer, Webster Kadzatsa, Joel Palefsky, Susan E Krown
PURPOSE: To determine the feasibility, safety, and tolerability of concomitant chemoradiotherapy administered at standard doses in HIV-infected women with locally-advanced cervical cancer (LACC) receiving antiretroviral therapy (ART). PATIENTS AND METHODS: Eligible participants had HIV infection and untreated, histologically-confirmed, invasive carcinoma of the uterine cervix, FIGO stages IB2, IIA (if tumor >4 cm), IIB, IIIA, IIIB, or IVA and met standard eligibility criteria...
February 15, 2019: Gynecologic Oncology
https://read.qxmd.com/read/30773184/helper-study-a-phase-ii-trial-of-continuous-infusion-of-endostar-combined-with-concurrent-etoposide-plus-cisplatin-and-radiotherapy-for-treatment-of-unresectable-stage-iii-non-small-cell-lung-cancer
#7
Yirui Zhai, Honglian Ma, Zhouguang Hui, Lujun Zhao, Dongming Li, Jun Liang, Xiaozhen Wang, Liming Xu, Bo Chen, Yu Tang, Runye Wu, Yujin Xu, Qingsong Pang, Ming Chen, Luhua Wang
PURPOSE: The prognosis of unresectable stage III non-small cell lung cancer (NSCLC) was poor even after concurrent chemoradiotherapy. There remains a great need to develop novel therapeutic agents in combination with CCRT to improve outcomes. This prospective study sought to evaluate the efficacy and toxicities of the addition of endostar, an anti-angiogenesis agent, to concurrent etoposide, cisplatin (EP) and radiotherapy for treatment of patients with NSCLC. PATIENTS AND METHODS: Patients with untreated pathologically confirmed inoperable stage III NSCLC were eligible...
February 2019: Radiotherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology
https://read.qxmd.com/read/30772671/initial-results-of-a-randomized-phase-iii-trial-of-high-dose-image-guided-radiation-with-or-without-androgen-deprivation-therapy-for-intermediate-risk-prostate-cancer
#8
Carlos E Vargas, Now Bahar Alam, Mitchell Terk, Joshua R Niska, Jamie Cesareti, Douglas Swartz, Apoorva Vashi, Ali Kasraeian, C Shawn West, Marc Blasser, Chris Moore
BACKGROUND: Prior randomized studies have shown a survival benefit using combined androgen deprivation therapy (ADT) and radiation therapy for intermediate-risk prostate cancer. However, these studies either used low doses of radiation (66.6 Gy to isocenter) or imaged guidance was not available. This study reports the initial differences for high dose image guided radiation with or without ADT. METHODS: From 2012 to 2014, 56 patients were treated with and 60 patients without 6 months of ADT (N = 116) in our phase III randomized trial for intermediate-risk prostate cancer...
February 10, 2019: Cancer Treatment and Research Communications
https://read.qxmd.com/read/30771764/locating-the-foramen-ovale-by-using-molar-and-inter-eminence-planes-a-guide-for-percutaneous-trigeminal-neuralgia-procedures
#9
Matthew J Zdilla, Brianna K Ritz, Nicholas S Nestor
OBJECTIVEThe first attempt to cannulate the foramen ovale is oftentimes unsuccessful and requires subsequent reattempts, thereby increasing the risk of an adverse event and radiation exposure to the patient and surgeon. Failure in cannulation may be attributable to variation in soft-tissue-based landmarks used for needle guidance. Also, the incongruity between guiding marks on the face and bony landmarks visible on fluoroscopic images may also complicate cannulation. Therefore, the object of this study was to assess the location of the foramen ovale by way of bony landmarks, exclusive of soft-tissue guidance...
February 15, 2019: Journal of Neurosurgery
https://read.qxmd.com/read/30770291/stereotactic-ablative-radiotherapy-versus-standard-radiotherapy-in-stage-1-non-small-cell-lung-cancer-trog-09-02-chisel-a-phase-3-open-label-randomised-controlled-trial
#10
David Ball, G Tao Mai, Shalini Vinod, Scott Babington, Jeremy Ruben, Tomas Kron, Brent Chesson, Alan Herschtal, Marijana Vanevski, Angela Rezo, Christine Elder, Marketa Skala, Andrew Wirth, Greg Wheeler, Adeline Lim, Mark Shaw, Penelope Schofield, Louis Irving, Benjamin Solomon
BACKGROUND: Stereotactic ablative body radiotherapy (SABR) is widely used to treat inoperable stage 1 non-small-cell lung cancer (NSCLC), despite the absence of prospective evidence that this type of treatment improves local control or prolongs overall survival compared with standard radiotherapy. We aimed to compare the two treatment techniques. METHODS: We did this multicentre, phase 3, randomised, controlled trial in 11 hospitals in Australia and three hospitals in New Zealand...
February 12, 2019: Lancet Oncology
https://read.qxmd.com/read/30758985/repeated-treatment-with-90-y-microspheres-in-intrahepatic-cholangiocarcinoma-relapsed-after-the-first-radioembolization
#11
Luca Filippi, Giovan Giuseppe Di Costanzo, Raffaella Tortora, Giuseppe Pelle, Roberto Cianni, Orazio Schillaci, Oreste Bagni
BACKGROUND: The aim of this study was to evaluate the safety and efficacy of repeated administration of 90 Y-microspheres in intrahepatic cholangiocarcinoma (ICC) relapsed after the first radioembolization (RE). METHODS: Nine patients with ICC relapsed after the first 90 Y-RE were enrolled. Six patients presented recurrence in the right hepatic lobe, 3 in the left lobe. All subjects underwent a second administration of 90 Y-resin microspheres. Toxicity was assessed according to Common Terminology Criteria for Adverse Events (CTCAE, version 4...
February 13, 2019: Cancer Biotherapy & Radiopharmaceuticals
https://read.qxmd.com/read/30753262/randomized-double-blind-placebo-controlled-trial-evaluating-oral-glutamine-on-radiation-induced-oral-mucositis-and-dermatitis-in-head-and-neck-cancer-patients
#12
Chih-Jen Huang, Ming-Yii Huang, Pen-Tzu Fang, Frank Chen, Yu-Tsang Wang, Chung-Ho Chen, Shyng-Shiou Yuan, Chun-Ming Huang, Kuei-Hau Luo, Hung-Yi Chuang, Yen-Yun Wang, Hsin-Hua Lee
Background: Glutamine is the primary fuel for the gastrointestinal epithelium and maintains the mucosal structure. Oncologists frequently encounter oral mucositis, which can cause unplanned breaks in radiotherapy (RT). Objectives: The aim of this study was to explore the association between oral glutamine and acute toxicities in patients with head and neck cancer undergoing RT. Methods: This was a parallel, double-blind, randomized, placebo-controlled Phase III trial conducted in a university hospital...
February 9, 2019: American Journal of Clinical Nutrition
https://read.qxmd.com/read/30746197/radiation-pneumonitis-in-lung-cancer-treated-with-volumetric-modulated-arc-therapy
#13
Kan Wu, Xiao Xu, Xiadong Li, Jiahao Wang, Lucheng Zhu, Xueqin Chen, Bing Wang, Minna Zhang, Bing Xia, Shenglin Ma
Background: Few studies to date have assessed the incidence of radiation pneumonitis (RP) in lung cancer patients who have been treated with volumetric modulated arc therapy (VMAT). This study is aimed at reporting the RP incidence rate and the risk factors associated with a symptomatic RP in patients with lung cancer treated with VMAT. Methods: A total of 77 consecutive lung cancer patients treated with VMAT from 2013 through 2015 were reviewed. RP severity was graded according to the Common Terminology Criteria for Adverse Events (CTCEA) v...
December 2018: Journal of Thoracic Disease
https://read.qxmd.com/read/30737574/the-eye-of-the-endourologist-what-are-the-risks-a-review-of-the-literature
#14
REVIEW
Steeve Doizi, Marie Audouin, Luca Villa, Maria Rodríguez-Monsalve Herrero, Vincent De Coninck, Etienne Xavier Keller, Olivier Traxer
PURPOSE: During endourological procedures, the eye of the urologist is exposed to hazards such as contact with body fluids and irrigation solutions as well as laser injury, and X-ray radiation absorption. The resulting potential injuries and damages to the eye have not been summarily reviewed to date. The objective was to review the different risks of exposure to the eyes of urologists during endourological procedures. METHODS: The Medline database was searched for identification of studies on hazards to the eye of the endourologist...
February 8, 2019: World Journal of Urology
https://read.qxmd.com/read/30736848/phase-ib-evaluation-of-a-self-adjuvanted-protamine-formulated-mrna-based-active-cancer-immunotherapy-bi1361849-cv9202-combined-with-local-radiation-treatment-in-patients-with-stage-iv-non-small-cell-lung-cancer
#15
Alexandros Papachristofilou, Madeleine M Hipp, Ute Klinkhardt, Martin Früh, Martin Sebastian, Christian Weiss, Miklos Pless, Richard Cathomas, Wolfgang Hilbe, Georg Pall, Thomas Wehler, Jürgen Alt, Helge Bischoff, Michael Geißler, Frank Griesinger, Karl-Josef Kallen, Mariola Fotin-Mleczek, Andreas Schröder, Birgit Scheel, Anke Muth, Tobias Seibel, Claudia Stosnach, Fatma Doener, Henoch S Hong, Sven D Koch, Ulrike Gnad-Vogt, Alfred Zippelius
BACKGROUND: Preclinical studies demonstrate synergism between cancer immunotherapy and local radiation, enhancing anti-tumor effects and promoting immune responses. BI1361849 (CV9202) is an active cancer immunotherapeutic comprising protamine-formulated, sequence-optimized mRNA encoding six non-small cell lung cancer (NSCLC)-associated antigens (NY-ESO-1, MAGE-C1, MAGE-C2, survivin, 5T4, and MUC-1), intended to induce targeted immune responses. METHODS: We describe a phase Ib clinical trial evaluating treatment with BI1361849 combined with local radiation in 26 stage IV NSCLC patients with partial response (PR)/stable disease (SD) after standard first-line therapy...
February 8, 2019: Journal for Immunotherapy of Cancer
https://read.qxmd.com/read/30735235/long-term-outcomes-of-stereotactic-body-radiotherapy-for-low-risk-and-intermediate-risk-prostate-cancer
#16
Amar U Kishan, Audrey Dang, Alan J Katz, Constantine A Mantz, Sean P Collins, Nima Aghdam, Fang-I Chu, Irving D Kaplan, Limor Appelbaum, Donald B Fuller, Robert M Meier, D Andrew Loblaw, Patrick Cheung, Huong T Pham, Narek Shaverdian, Naomi Jiang, Ye Yuan, Hilary Bagshaw, Nicolas Prionas, Mark K Buyyounouski, Daniel E Spratt, Patrick W Linson, Robert L Hong, Nicholas G Nickols, Michael L Steinberg, Patrick A Kupelian, Christopher R King
Importance: Stereotactic body radiotherapy harnesses improvements in technology to allow the completion of a course of external beam radiotherapy treatment for prostate cancer in the span of 4 to 5 treatment sessions. Although mounting short-term data support this approach, long-term outcomes have been sparsely reported. Objective: To assess long-term outcomes after stereotactic body radiotherapy for low-risk and intermediate-risk prostate cancer. Design, Setting, and Participants: This cohort study analyzed individual patient data from 2142 men enrolled in 10 single-institution phase 2 trials and 2 multi-institutional phase 2 trials of stereotactic body radiotherapy for low-risk and intermediate-risk prostate cancer between January 1, 2000, and December 31, 2012...
February 1, 2019: JAMA network open
https://read.qxmd.com/read/30721721/outcomes-of-a-dose-escalated-stereotactic-body-radiation-phase-i-ii-trial-for-patients-with-low-and-intermediate-risk-prostate-cancer
#17
Louis Potters, Zaker Rana, Lucille Lee, Brett W Cox
INTRODUCTION: This study presents a prospective phase I, IRB-approved dose-escalated stereotactic body radiotherapy (SBRT) trial for prostate cancer (CaP) to assess the impact of dose level on quality of life, toxicity, and clinical outcomes. MATERIALS/METHODS: From 2011-2016, 26 patients with low and intermediate-risk CaP received 40, 45, and 50 Gy in five fractions to the prostate in cohorts of 9, 10, and 7 patients. Self-reported QOL was prospectively measured from the Expanded Prostate Cancer Index Composite (EPIC) and American Urological Association (AUA)...
February 2, 2019: International Journal of Radiation Oncology, Biology, Physics
https://read.qxmd.com/read/30719359/adhesion-ileus-after-fecal-microbiota-transplantation-in-long-standing-radiation-colitis
#18
Igor Alexander Harsch, Peter Christopher Konturek
Fecal microbiota transplantation (FMT) is a novel strategy for the therapy of dysbiosis-associated disorders via modulation of the gut microbiota. Intestinal dysbiosis is associated not only with digestive disorders, but also with a variety of extra-digestive disorders. A worldwide increasing number of FMT can be expected in the future as well as an increase in adverse events. We describe the case of a patient with chronic radiation colitis that developed adhesion ileus 2 days after FMT. Since these problems never occured before and the short time interval favours a causality, we speculate about FMT-induced alterations in gut motility causing a "trapping" of the small intestine in an adhesion and other mechanisms beyond "pure" coincidence...
2019: Case Reports in Gastrointestinal Medicine
https://read.qxmd.com/read/30711957/cancer-site-and-adverse-events-induced-by-immune-checkpoint-inhibitors-a-retrospective-analysis-of-real-life-experience-at-a-single-institution
#19
Ammar Sukari, Misako Nagasaka, Roba Alhasan, Dhaval Patel, Antoinette Wozniak, Radhakrishnan Ramchandren, Ulka Vaishampayan, Amy Weise, Lawrence Flaherty, Hyejeong Jang, Seongho Kim, Shirish Gadgeel
BACKGROUND: Data on the characteristics of patients who are likely to experience adverse events, both immune-related and non-immune-related, from programmed cell death-1 (PD1) inhibitors are limited. PATIENTS AND METHODS: Data from patients who received ≥1 dose of single-agent PD1 inhibitor between August 3, 2011 and August 31, 2016 were obtained from our Institution's pharmacy database. AEs were graded using Common Terminology Criteria for Adverse Events version 4...
February 2019: Anticancer Research
https://read.qxmd.com/read/30706022/a-multi-institutional-experience-of-mr-guided-liver-stereotactic-body-radiation-therapy
#20
Stephen A Rosenberg, Lauren E Henke, Narek Shaverdian, Kathryn Mittauer, Andrzej P Wojcieszynski, Craig R Hullett, Mitchell Kamrava, James Lamb, Minsong Cao, Olga L Green, Rojano Kashani, Bhudatt Paliwal, John Bayouth, Paul M Harari, Jeffrey R Olsen, Percy Lee, Parag J Parikh, Michael Bassetti
Purpose: Daily magnetic resonance (MR)-guided radiation has the potential to improve stereotactic body radiation therapy (SBRT) for tumors of the liver. Magnetic resonance imaging (MRI) introduces unique variables that are untested clinically: electron return effect, MRI geometric distortion, MRI to radiation therapy isocenter uncertainty, multileaf collimator position error, and uncertainties with voxel size and tracking. All could lead to increased toxicity and/or local recurrences with SBRT...
January 2019: Advances in Radiation Oncology
keyword
keyword
160170
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"